世界の治療用酵素薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Therapeutic Enzyme Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5617
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、治療用酵素薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射剤、経口、局所）、用途別市場規模（ゴーシェ病、MPS病、胃腸疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・治療用酵素薬の市場動向
・企業の競争状況、市場シェア
・治療用酵素薬の種類別市場規模（注射剤、経口、局所）
・治療用酵素薬の用途別市場規模（ゴーシェ病、MPS病、胃腸疾患、その他）
・治療用酵素薬の北米市場規模2016-2027（アメリカ、カナダ）
・治療用酵素薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・治療用酵素薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・治療用酵素薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・治療用酵素薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sanofi、BioMarin、AbbVie、Shire、Alexion、Horizon Pharma、Allergan、Johnson & Johnson、Recordati Rare Diseases、Pfizer、Vivus、Digestive Care）
・結論

Market Analysis and Insights: Global Therapeutic Enzyme Drugs Market
The global Therapeutic Enzyme Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Enzyme Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Enzyme Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Enzyme Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Enzyme Drugs market.

Global Therapeutic Enzyme Drugs Scope and Market Size
Therapeutic Enzyme Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Enzyme Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Injectable
Oral
Topical

Segment by Application
Gaucher Disease
MPS Disease
Gastrointestinal Diseases
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injectable
1.2.3 Oral
1.2.4 Topical
1.3 Market by Application
1.3.1 Global Therapeutic Enzyme Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Gaucher Disease
1.3.3 MPS Disease
1.3.4 Gastrointestinal Diseases
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Therapeutic Enzyme Drugs Market Perspective (2016-2027)
2.2 Therapeutic Enzyme Drugs Growth Trends by Regions
2.2.1 Therapeutic Enzyme Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Therapeutic Enzyme Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Therapeutic Enzyme Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Therapeutic Enzyme Drugs Industry Dynamic
2.3.1 Therapeutic Enzyme Drugs Market Trends
2.3.2 Therapeutic Enzyme Drugs Market Drivers
2.3.3 Therapeutic Enzyme Drugs Market Challenges
2.3.4 Therapeutic Enzyme Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Enzyme Drugs Players by Revenue
3.1.1 Global Top Therapeutic Enzyme Drugs Players by Revenue (2016-2021)
3.1.2 Global Therapeutic Enzyme Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Therapeutic Enzyme Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Enzyme Drugs Revenue
3.4 Global Therapeutic Enzyme Drugs Market Concentration Ratio
3.4.1 Global Therapeutic Enzyme Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Enzyme Drugs Revenue in 2020
3.5 Therapeutic Enzyme Drugs Key Players Head office and Area Served
3.6 Key Players Therapeutic Enzyme Drugs Product Solution and Service
3.7 Date of Enter into Therapeutic Enzyme Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Enzyme Drugs Breakdown Data by Type
4.1 Global Therapeutic Enzyme Drugs Historic Market Size by Type (2016-2021)
4.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2022-2027)

5 Therapeutic Enzyme Drugs Breakdown Data by Application
5.1 Global Therapeutic Enzyme Drugs Historic Market Size by Application (2016-2021)
5.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Therapeutic Enzyme Drugs Market Size (2016-2027)
6.2 North America Therapeutic Enzyme Drugs Market Size by Type
6.2.1 North America Therapeutic Enzyme Drugs Market Size by Type (2016-2021)
6.2.2 North America Therapeutic Enzyme Drugs Market Size by Type (2022-2027)
6.2.3 North America Therapeutic Enzyme Drugs Market Size by Type (2016-2027)
6.3 North America Therapeutic Enzyme Drugs Market Size by Application
6.3.1 North America Therapeutic Enzyme Drugs Market Size by Application (2016-2021)
6.3.2 North America Therapeutic Enzyme Drugs Market Size by Application (2022-2027)
6.3.3 North America Therapeutic Enzyme Drugs Market Size by Application (2016-2027)
6.4 North America Therapeutic Enzyme Drugs Market Size by Country
6.4.1 North America Therapeutic Enzyme Drugs Market Size by Country (2016-2021)
6.4.2 North America Therapeutic Enzyme Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Therapeutic Enzyme Drugs Market Size (2016-2027)
7.2 Europe Therapeutic Enzyme Drugs Market Size by Type
7.2.1 Europe Therapeutic Enzyme Drugs Market Size by Type (2016-2021)
7.2.2 Europe Therapeutic Enzyme Drugs Market Size by Type (2022-2027)
7.2.3 Europe Therapeutic Enzyme Drugs Market Size by Type (2016-2027)
7.3 Europe Therapeutic Enzyme Drugs Market Size by Application
7.3.1 Europe Therapeutic Enzyme Drugs Market Size by Application (2016-2021)
7.3.2 Europe Therapeutic Enzyme Drugs Market Size by Application (2022-2027)
7.3.3 Europe Therapeutic Enzyme Drugs Market Size by Application (2016-2027)
7.4 Europe Therapeutic Enzyme Drugs Market Size by Country
7.4.1 Europe Therapeutic Enzyme Drugs Market Size by Country (2016-2021)
7.4.2 Europe Therapeutic Enzyme Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size (2016-2027)
8.2 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type
8.2.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application
8.3.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region
8.4.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Therapeutic Enzyme Drugs Market Size (2016-2027)
9.2 Latin America Therapeutic Enzyme Drugs Market Size by Type
9.2.1 Latin America Therapeutic Enzyme Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Therapeutic Enzyme Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Therapeutic Enzyme Drugs Market Size by Type (2016-2027)
9.3 Latin America Therapeutic Enzyme Drugs Market Size by Application
9.3.1 Latin America Therapeutic Enzyme Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Therapeutic Enzyme Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Therapeutic Enzyme Drugs Market Size by Application (2016-2027)
9.4 Latin America Therapeutic Enzyme Drugs Market Size by Country
9.4.1 Latin America Therapeutic Enzyme Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Therapeutic Enzyme Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size (2016-2027)
10.2 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type
10.2.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application
10.3.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country
10.4.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Therapeutic Enzyme Drugs Introduction
11.1.4 Sanofi Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 BioMarin
11.2.1 BioMarin Company Details
11.2.2 BioMarin Business Overview
11.2.3 BioMarin Therapeutic Enzyme Drugs Introduction
11.2.4 BioMarin Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.2.5 BioMarin Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Therapeutic Enzyme Drugs Introduction
11.3.4 AbbVie Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Shire
11.4.1 Shire Company Details
11.4.2 Shire Business Overview
11.4.3 Shire Therapeutic Enzyme Drugs Introduction
11.4.4 Shire Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.4.5 Shire Recent Development
11.5 Alexion
11.5.1 Alexion Company Details
11.5.2 Alexion Business Overview
11.5.3 Alexion Therapeutic Enzyme Drugs Introduction
11.5.4 Alexion Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.5.5 Alexion Recent Development
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Horizon Pharma Business Overview
11.6.3 Horizon Pharma Therapeutic Enzyme Drugs Introduction
11.6.4 Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.6.5 Horizon Pharma Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Therapeutic Enzyme Drugs Introduction
11.7.4 Allergan Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.7.5 Allergan Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Therapeutic Enzyme Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Recordati Rare Diseases
11.9.1 Recordati Rare Diseases Company Details
11.9.2 Recordati Rare Diseases Business Overview
11.9.3 Recordati Rare Diseases Therapeutic Enzyme Drugs Introduction
11.9.4 Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.9.5 Recordati Rare Diseases Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Therapeutic Enzyme Drugs Introduction
11.10.4 Pfizer Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 Vivus
11.11.1 Vivus Company Details
11.11.2 Vivus Business Overview
11.11.3 Vivus Therapeutic Enzyme Drugs Introduction
11.11.4 Vivus Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.11.5 Vivus Recent Development
11.12 Digestive Care
11.12.1 Digestive Care Company Details
11.12.2 Digestive Care Business Overview
11.12.3 Digestive Care Therapeutic Enzyme Drugs Introduction
11.12.4 Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2016-2021)
11.12.5 Digestive Care Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injectable
Table 3. Key Players of Oral
Table 4. Key Players of Topical
Table 5. Global Therapeutic Enzyme Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Therapeutic Enzyme Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Therapeutic Enzyme Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Therapeutic Enzyme Drugs Market Share by Regions (2016-2021)
Table 9. Global Therapeutic Enzyme Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Therapeutic Enzyme Drugs Market Share by Regions (2022-2027)
Table 11. Therapeutic Enzyme Drugs Market Trends
Table 12. Therapeutic Enzyme Drugs Market Drivers
Table 13. Therapeutic Enzyme Drugs Market Challenges
Table 14. Therapeutic Enzyme Drugs Market Restraints
Table 15. Global Therapeutic Enzyme Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Therapeutic Enzyme Drugs Market Share by Players (2016-2021)
Table 17. Global Top Therapeutic Enzyme Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Enzyme Drugs as of 2020)
Table 18. Ranking of Global Top Therapeutic Enzyme Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Therapeutic Enzyme Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Therapeutic Enzyme Drugs Product Solution and Service
Table 22. Date of Enter into Therapeutic Enzyme Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Therapeutic Enzyme Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Therapeutic Enzyme Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Therapeutic Enzyme Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Therapeutic Enzyme Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Therapeutic Enzyme Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Therapeutic Enzyme Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Therapeutic Enzyme Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Therapeutic Enzyme Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Therapeutic Enzyme Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Therapeutic Enzyme Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Therapeutic Enzyme Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Therapeutic Enzyme Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Therapeutic Enzyme Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Therapeutic Enzyme Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Therapeutic Enzyme Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Therapeutic Enzyme Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Therapeutic Enzyme Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Therapeutic Enzyme Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Therapeutic Enzyme Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Therapeutic Enzyme Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Therapeutic Enzyme Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Therapeutic Enzyme Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Therapeutic Enzyme Drugs Product
Table 65. Sanofi Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. BioMarin Company Details
Table 68. BioMarin Business Overview
Table 69. BioMarin Therapeutic Enzyme Drugs Product
Table 70. BioMarin Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 71. BioMarin Recent Development
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Therapeutic Enzyme Drugs Product
Table 75. AbbVie Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 76. AbbVie Recent Development
Table 77. Shire Company Details
Table 78. Shire Business Overview
Table 79. Shire Therapeutic Enzyme Drugs Product
Table 80. Shire Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 81. Shire Recent Development
Table 82. Alexion Company Details
Table 83. Alexion Business Overview
Table 84. Alexion Therapeutic Enzyme Drugs Product
Table 85. Alexion Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 86. Alexion Recent Development
Table 87. Horizon Pharma Company Details
Table 88. Horizon Pharma Business Overview
Table 89. Horizon Pharma Therapeutic Enzyme Drugs Product
Table 90. Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 91. Horizon Pharma Recent Development
Table 92. Allergan Company Details
Table 93. Allergan Business Overview
Table 94. Allergan Therapeutic Enzyme Drugs Product
Table 95. Allergan Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 96. Allergan Recent Development
Table 97. Johnson & Johnson Company Details
Table 98. Johnson & Johnson Business Overview
Table 99. Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 100. Johnson & Johnson Recent Development
Table 101. Recordati Rare Diseases Company Details
Table 102. Recordati Rare Diseases Business Overview
Table 103. Recordati Rare Diseases Therapeutic Enzyme Drugs Product
Table 104. Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 105. Recordati Rare Diseases Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Therapeutic Enzyme Drugs Product
Table 109. Pfizer Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 110. Pfizer Recent Development
Table 111. Vivus Company Details
Table 112. Vivus Business Overview
Table 113. Vivus Therapeutic Enzyme Drugs Product
Table 114. Vivus Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 115. Vivus Recent Development
Table 116. Digestive Care Company Details
Table 117. Digestive Care Business Overview
Table 118. Digestive Care Therapeutic Enzyme Drugs Product
Table 119. Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2016-2021) & (US$ Million)
Table 120. Digestive Care Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Enzyme Drugs Market Share by Type: 2020 VS 2027
Figure 2. Injectable Features
Figure 3. Oral Features
Figure 4. Topical Features
Figure 5. Global Therapeutic Enzyme Drugs Market Share by Application: 2020 VS 2027
Figure 6. Gaucher Disease Case Studies
Figure 7. MPS Disease Case Studies
Figure 8. Gastrointestinal Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. Therapeutic Enzyme Drugs Report Years Considered
Figure 11. Global Therapeutic Enzyme Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Therapeutic Enzyme Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Therapeutic Enzyme Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Therapeutic Enzyme Drugs Market Share by Regions (2022-2027)
Figure 15. Global Therapeutic Enzyme Drugs Market Share by Players in 2020
Figure 16. Global Top Therapeutic Enzyme Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Enzyme Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Therapeutic Enzyme Drugs Revenue in 2020
Figure 18. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Therapeutic Enzyme Drugs Market Share by Type (2016-2027)
Figure 22. North America Therapeutic Enzyme Drugs Market Share by Application (2016-2027)
Figure 23. North America Therapeutic Enzyme Drugs Market Share by Country (2016-2027)
Figure 24. United States Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Therapeutic Enzyme Drugs Market Share by Type (2016-2027)
Figure 28. Europe Therapeutic Enzyme Drugs Market Share by Application (2016-2027)
Figure 29. Europe Therapeutic Enzyme Drugs Market Share by Country (2016-2027)
Figure 30. Germany Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Therapeutic Enzyme Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Therapeutic Enzyme Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Therapeutic Enzyme Drugs Market Share by Region (2016-2027)
Figure 40. China Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Therapeutic Enzyme Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Therapeutic Enzyme Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Therapeutic Enzyme Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Therapeutic Enzyme Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Therapeutic Enzyme Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Therapeutic Enzyme Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Therapeutic Enzyme Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 60. BioMarin Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 62. Shire Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 63. Alexion Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 64. Horizon Pharma Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 65. Allergan Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 67. Recordati Rare Diseases Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 69. Vivus Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 70. Digestive Care Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の眼科治療薬市場規模・現状・予測（2021年-2027年）

Global Ophthalmic Therapeutic Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z4274 2021年4月 93Pages
QYResearch社発行の本調査資料では、眼科治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他）、用途別市場規模（病院薬局、オンライン薬局、独立型薬局＆ドラッグストア）...

世界の組換え治療用抗体＆タンパク質市場規模・現状・予測（2021年-2027年）

Global Recombinant Therapeutic Antibodies and Proteins Market Size, Status and Forecast 2021-2027
QYR2104Z4961 2021年4月 93Pages
QYResearch社発行の本調査資料では、組換え治療用抗体＆タンパク質のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血漿タンパク質、融合タンパク質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他）、用途別市場規模（腫瘍、血液、免疫、内...

世界のアデノシンデアミナーゼ欠損症（ADA）治療薬市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z0095 2021年4月 99Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の色素沈着障害治療市場規模・現状・予測（2021年-2027年）

Global Pigmentation Disorder Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z4618 2021年4月 96Pages
QYResearch社発行の本調査資料では、色素沈着障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸など）、美容治療（ケミカルピーリング、レーザー治療、植皮など））、用途別市場規模（皮...

世界のループス治療市場規模・現状・予測（2021年-2027年）

Global Lupus Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z3498 2021年4月 92Pages
QYResearch社発行の本調査資料では、ループス治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B細胞モジュレーター、T細胞モジュレーター、免疫抑制剤・細胞毒性薬、炎症誘発性・サイトカイン阻害剤、その他）、用途別市場規模（クリニック、病...

世界の中枢神経系（CNS）治療市場規模・現状・予測（2021年-2027年）

Global Central Nervous System Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z1230 2021年4月 99Pages
QYResearch社発行の本調査資料では、中枢神経系（CNS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の大うつ病性障害治療市場規模・現状・予測（2021年-2027年）

Global Major Depressive Disorder Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z3530 2021年4月 91Pages
QYResearch社発行の本調査資料では、大うつ病性障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、生物学的療法、瞑想、理学療法、その他）、用途別市場規模（25歳以下、25〜45歳、45歳以上）、主要地域別市場規模（北米、ア...

世界のスルホトランスフェラーゼ酵素市場規模・現状・予測（2021年-2027年）

Global Sulfotransferase Enzyme Market Size, Status and Forecast 2021-2027
QYR2104Z5493 2021年4月 91Pages
QYResearch社発行の本調査資料では、スルホトランスフェラーゼ酵素のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模（北米...

世界のスルホトランスフェラーゼ酵素市場規模・現状・予測（2021年-2027年）

世界の悪性神経膠腫治療市場規模・現状・予測（2021年-2027年）

Global Malignant Glioma Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z3542 2021年4月 93Pages
QYResearch社発行の本調査資料では、悪性神経膠腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、薬物）、用途別市場規模（病院、がん研究機関、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の眼科治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 22640 million by 2026, from US$ 15860 million in 2019, at a CAGR of 5.2% during 2021-2026. With industry-standard accuracy in analysis and high data …
世界の腸疾患検査・治療市場規模・現状・予測（2021年-2027年） Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases. Ac…
世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals. Market Analysis and Insights: Global Crohn…
世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals. Market Analysis and Insights: Global Crohn…
世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Crohn's Disease Diagnostic and Therapeutic Market The global Crohn's Disease Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…